Johns Hopkins School of Medicine
Johns Hopkins School of Medicine
Baltimore, Maryland, United States21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Producing Increasingly Complex Themes Using Right-hemisphere Engagement (PICTURE) Implemented With Telemedicine | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, language disorder, nervous system disorder, speech disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-09-08 | NCT05845047 | |
| Escitalopram and Language Intervention for Subacute Aphasia | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, language disorder, nervous system disorder, speech disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 | 2026-09-03 | NCT03843463 | |
| The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Not applicable | 2026-09-02 | NCT06796504 | |
| Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Enrolling by invitation | Phase 2 | 2026-08-26 | NCT07393373 | |
| AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epileptic Syndromes, Hippocampal Sclerosis, Malformations of Cortical Development, Group I, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-24 | NCT06063850 | |
| Rapid Evacuation and Access of Cerebral Hemorrhage Trial | Embolism and Thrombosis, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, intracerebral hemorrhage, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder | Recruiting | Not applicable | 2026-08-14 | NCT06870812 | |
| An Interventional Study of Infigratinib in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Enrolling by invitation | Phase 2 / Phase 3 | 2026-07-16 | NCT06873035 | |
| Prospective Clinical Assessment Study in Children With Hypochondroplasia | Bone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, cutaneous mucinosis, endocrine system disorder, hereditary disease, hypochondroplasia, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Not stated | 2026-07-16 | NCT06410976 | |
| Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-06-18 | NCT05989230 | |
| Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-12 | NCT05563220 | |
| Biliary Atresia Study in Infants and Children | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, bile duct disorder, biliary atresia, biliary tract disorder, cholestasis | Recruiting | Not stated | 2026-06-04 | NCT00345553 | |
| A Prospective Database of Infants With Cholestasis | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, bile duct disorder, biliary atresia, biliary tract disorder | Recruiting | Not stated | 2026-06-04 | NCT00061828 | |
| Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-05-15 | NCT06564142 | |
| Night Owl Metabolism | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, metabolic disease, nutritional disorder, overnutrition, prediabetes syndrome | Recruiting | Not applicable | 2026-05-11 | NCT06507722 | |
| Long Term Outcomes After Vestibular Implantation | Bilateral Vestibulopathy, Chemically-Induced Disorders, Dizziness, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cerebellar ataxia, intellectual disability, and dysequilibrium, injury, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, radiation injury, vestibular disorder | Recruiting | Not applicable | 2026-03-09 | NCT06500975 | |
| Multichannel Vestibular Implant Early Feasibility Study | Bilateral Vestibulopathy, Chemically-Induced Disorders, Dizziness, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cerebellar ataxia, intellectual disability, and dysequilibrium, injury, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, radiation injury, vestibular disorder | Active, not recruiting | Not applicable | 2026-03-09 | NCT02725463 | |
| Alcohol Research in HIV: Relapse Prevention | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-02-18 | NCT05163301 | |
| Vestibular Implantation in Older Adults | Age-Related Vestibular Loss, Bilateral Vestibulopathy, Chemically-Induced Disorders, Dizziness, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cerebellar ataxia, intellectual disability, and dysequilibrium, injury, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, radiation injury, vestibular disorder | Recruiting | Not applicable | 2026-01-12 | NCT05676944 | |
| Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction | Bilateral Vestibulopathy, Chemically-Induced Disorders, Dizziness, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cerebellar ataxia, intellectual disability, and dysequilibrium, injury, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, radiation injury, vestibular disorder | Recruiting | Not applicable | 2026-01-12 | NCT05674786 | |
| Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Pelvic Infection, Urogenital Diseases, female reproductive system disorder, pelvic inflammatory disease | Active, not recruiting | Not applicable | 2025-11-14 | NCT03828994 | |
| A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2025-08-17 | NCT05027477 |